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FOR THE MEDICAL EDITORS TRIAL AMNESTY
Reports of properly conducted randomized, controlled trials
are the foundation of safe and effective health care. However,
a substantial proportion of all controlled trials never contribute
to this knowledge base because they are not submitted for
publication (1,2). This fact has a number of important impli-
cations for patient care: 1) Underreporting of trials reduces the
power of systematic reviews to detect moderate but clinically
important treatment effects. As a result, patients may be
denied effective forms of health care. 2) Because trials that
show more promising treatment effects are more likely to be
submitted for publication, research syntheses based on pub-
lished studies can give misleading conclusions about treatment
effectiveness, thus exposing patients to useless or even harmful
therapies (3). 3) Patients may be asked to participate in new
research studies designed to address questions that have, in
truth, already been answered (4).
Trials go unreported for a myriad of reasons: The most
common is that investigators think that the results are “not
interesting,” and it is well documented that trials with nonsig-
nificant results are substantially less likely to be submitted for
publication (1). Sometimes, participant recruitment takes
longer than anticipated at the expense of time and resources
set aside for report writing; investigators may change jobs, with
the result that important work remains unfinished; or an
investigator may discover a recently published trial on the same
topic and conclude that their own results are now redundant.
Editors must also take some of the responsibility. There is a
limit to the number of reports that we can publish, and we are
sometimes forced to decline publication. Many investigators
regret not having published their trial results, and almost all
investigators when contacted about unreported data are de-
lighted to provide it.
Because of the important consequences of unreported
trials, the editors of nearly 100 international medical journals
have joined together to call an unreported trial amnesty.
Although amnesty means giving pardon, we hope that investi-
gators will see this as an opportunity—namely, to make the
results of previously unreported trials publicly accessible, thus
having the potential to contribute to the scientific foundation
of health care. We urge all investigators with unreported trial
data to register their trial or trials by filling in and returning an
unreported trial registration form (see Appendix). We would
like to register any unreported controlled trial, including trials
that have only been published in abstract form. Registration
can be undertaken by anyone able to provide the registration
information, even if they are unable to provide the actual trial
data. We expect a degree of duplicate registration. Registra-
tion information can be posted or faxed to the editorial offices
of this Journal. Alternatively, registration information can be
sent by e-mail (meta@ucl.ac.uk). The information will be
made available by listing the trial details on a Web site and in
other ways, as appropriate. If specific trial data are required,
for example, by those conducting systematic reviews, then the
reviewer will be able to seek this information directly from the
trialist. Some of the trials may be suitable for full publication,
and the Journal will be happy to consider these.
Medical editors are acutely aware of the trials and tribula-
tions of research reporting. But on this occasion, because of
the serious implications of unreported research, we are en-
deavoring to cleave the trials from the tribulations. We cannot
confidently estimate the total number of unreported trials, but
we are confident of a good response.
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Appendix
Unreported trial registration form
Register any controlled trial which has not been published in full, including trials that have only been published as an abstract.
Registration can be undertaken by anyone able to provide the registration information, even if they are unable to provide the
actual trial data. Please complete one form for each trial being registered.
Contact details
Surname: Forename(s):
Postal address: Phone (with regional codes):
Fax (with regional codes):
E-mail:
Trial details
Approximate number of participants in the trial:
Type of participants (e.g. people with head injury, women at risk of breast cancer):
Type of intervention (e.g. steroids versus placebo, annual mammography versus standard practice):
versus
Please post or fax completed registration forms to:
Medical Editors Trial Amnesty
Journal of the American College of Cardiology
William W. Parmley, MD
415 Judah Street
San Francisco, CA 94122
Fax: 415-759-0251
Alternatively, the above information can be sent by E-mail to: meta@ucl.ac.uk
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